Global registry targets dangerous bleeding during stroke clot removal

NCT ID NCT06394180

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

The PREVENT study is a large, worldwide registry that will track 1,000 stroke patients who undergo a clot-removal procedure called thrombectomy. Researchers want to understand why a blood vessel sometimes gets poked during the procedure, causing dangerous bleeding. By studying medical images and patient outcomes, they hope to create a simple classification system to help doctors quickly decide how to stop the bleeding and whether to continue the procedure. This is an observational study, so it won't test a new drug or device, but it could lead to safer techniques and better emergency care.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could lead to safer thrombectomy procedures and better emergency management of vessel perforations during stroke treatment.
What could go wrong
This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Results may take years to influence practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University Hospital Basel

    RECRUITING

    Basel, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.